ACUTE MIGRAINE

Clinical trials for ACUTE MIGRAINE explained in plain language.

Never miss a new study

Get alerted when new ACUTE MIGRAINE trials appear

Sign up with your email to follow new studies for ACUTE MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1 Terminated 1

Migraine drug tested for Long-Term safety in 1,000-Person trial

Symptom relief Recruiting now

This phase 3 study evaluates the long-term safety of elismetrep (K-304), an oral medication taken as needed for migraine attacks. About 1,000 adults who previously took elismetrep in an earlier trial will continue using it intermittently. Researchers will track side effects over …

Matched conditions: ACUTE MIGRAINE

Phase: PHASE3 • Sponsor: Kallyope Inc. • Aim: Symptom relief

Last updated Aug 14, 2026 00:00 UTC

ACUTE MIGRAINE

Get alerted when new ACUTE MIGRAINE trials appear

Migraine drug tested for Long-Term safety in 1,000-Person trial